NATIONAL DESK
| November 21,
2002, Thursday
Results of Elections Give Pharmaceutical Industry New
Influence in Congress
By ROBERT PEAR
and RICHARD A. OPPEL Jr. (NYT) 1169 words
Late Edition -
Final, Section A, Page 34, Column 1
LEAD
PARAGRAPH -
Having spent more than $30 million to help elect their allies to
Congress, the major drug companies are devising ways to capitalize
on their electoral success by securing favorable new legislation and
countering the pressure that lawmakers in both parties feel to lower
the cost of prescription drugs, industry officials say.
The industry's hand appears stronger now than at any other time
in recent years, a result of its large donations to political
parties and candidates and millions of dollars spent on television
advertising by industry-financed groups. The money was spent
overwhelmingly on behalf of Republicans, who now control both houses
of Congress.
You can purchase this article:
As a single article for $2.95
As part of an Article 4 Pack for $ 7.95 - A 33% savings.
As part of an Article 10 Pack for $15.95 - A 46% savings.
As part of an Article 25 Pack for $25.95 - A 65% savings.
Click here to purchase article if you already own an archive article
pack.
Premium Archive articles do not currently include photos,
charts, or graphics of any kind.
|